| Date | Form | Description | Docs | XBRL | Pages |
| 01/28/13 | 8-K | Current report filing |
|
3 | |
| 12/07/12 | 3 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/04/12 | 8-K | Current report filing |
|
5 | |
| 12/04/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/04/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 12/04/12 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/15/12 | CT ORDER | Confidential treatment order |
|
1 | |
| 11/08/12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
2 | |
| 11/08/12 | 8-K | Current report filing |
|
20 | |
| 11/06/12 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
|
2 |
Latest News & Events
Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board
Read More...Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties
Read More...Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress
Read More...